Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Supporting babies at high risk of cerebral palsy from the very beginning

July 1, 2026
Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.
Read Transcript

The challenge

Cerebral palsy (CP) is the most common physical disability in childhood, affecting movement, posture and, for many children, speech, learning, feeding and other aspects of development. Every day in Australia, two babies are born with CP (Cerebral Palsy Alliance Research Institute, Sydney, 2023). While it is now possible to identify many infants at high risk within weeks of birth, access to evidence-based early intervention remains limited and inconsistent.

The first months of life are a critical period for brain development, when an infant's brain has its greatest capacity to adapt and learn. Supporting parents during this time is equally important, yet families of infants at high risk of CP often receive little structured support, despite mothers being more than 15 times more likely to experience depression than mothers of infants without CP.

A new approach to early intervention

Adjunct Associate Professor Cathy Morgan and Professor Nadia Badawi from Cerebral Palsy Alliance are evaluating the Very early Intensive Programme (VIP), a six-month intervention for babies identified as being at high risk of CP. Beginning when babies are between birth and four weeks’ corrected age, the program combines customised motor training and environmental enrichment with parent support and coaching.

The randomised controlled trial will involve 138 infants and compare the VIP with the standard parent education and monitoring that families currently receive. The study will assess whether the program improves infants' motor, cognitive and communication development, while also supporting parents' wellbeing, confidence and quality of life.

Early impact

The study is now underway, with recruitment across 10 neonatal intensive care units and special care nurseries in New South Wales. To date, 27 infants have been screened for eligibility, and 19 families have been enrolled in the trial. Although the study is still recruiting participants and analysis has yet to begin, many families have already shared positive feedback about their experience with the VIP intervention.

Parents have spoken about the value of the customised, family-centred approach and the confidence they have gained through personalised coaching and support during the first months of their baby's life. Several families have also reached out to the research team to express their appreciation for the program. 

Beyond the trial, a monthly peer support group, led by parents with lived experience of raising a child with CP, has been established to help families connect with others navigating similar experiences. Resources have also been developed to support health professionals in having early diagnostic conversations with families. Listen to the podcast below to learn more about why these early conversations matter.

What this could unlock

If successful, the VIP Study will provide important evidence to guide the delivery of early intervention for infants at high risk of CP. The research aims to inform future clinical practice and policy, helping ensure families receive evidence-based, family-centred support during the earliest stages of their child's development. Researchers also hope to expand the model for families living in regional and remote Australia, where access to specialist allied health services is often limited.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

The challenge

Cerebral palsy (CP) is the most common physical disability in childhood, affecting movement, posture and, for many children, speech, learning, feeding and other aspects of development. Every day in Australia, two babies are born with CP (Cerebral Palsy Alliance Research Institute, Sydney, 2023). While it is now possible to identify many infants at high risk within weeks of birth, access to evidence-based early intervention remains limited and inconsistent.

The first months of life are a critical period for brain development, when an infant's brain has its greatest capacity to adapt and learn. Supporting parents during this time is equally important, yet families of infants at high risk of CP often receive little structured support, despite mothers being more than 15 times more likely to experience depression than mothers of infants without CP.

A new approach to early intervention

Adjunct Associate Professor Cathy Morgan and Professor Nadia Badawi from Cerebral Palsy Alliance are evaluating the Very early Intensive Programme (VIP), a six-month intervention for babies identified as being at high risk of CP. Beginning when babies are between birth and four weeks’ corrected age, the program combines customised motor training and environmental enrichment with parent support and coaching.

The randomised controlled trial will involve 138 infants and compare the VIP with the standard parent education and monitoring that families currently receive. The study will assess whether the program improves infants' motor, cognitive and communication development, while also supporting parents' wellbeing, confidence and quality of life.

Early impact

The study is now underway, with recruitment across 10 neonatal intensive care units and special care nurseries in New South Wales. To date, 27 infants have been screened for eligibility, and 19 families have been enrolled in the trial. Although the study is still recruiting participants and analysis has yet to begin, many families have already shared positive feedback about their experience with the VIP intervention.

Parents have spoken about the value of the customised, family-centred approach and the confidence they have gained through personalised coaching and support during the first months of their baby's life. Several families have also reached out to the research team to express their appreciation for the program. 

Beyond the trial, a monthly peer support group, led by parents with lived experience of raising a child with CP, has been established to help families connect with others navigating similar experiences. Resources have also been developed to support health professionals in having early diagnostic conversations with families. Listen to the podcast below to learn more about why these early conversations matter.

What this could unlock

If successful, the VIP Study will provide important evidence to guide the delivery of early intervention for infants at high risk of CP. The research aims to inform future clinical practice and policy, helping ensure families receive evidence-based, family-centred support during the earliest stages of their child's development. Researchers also hope to expand the model for families living in regional and remote Australia, where access to specialist allied health services is often limited.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
February 24, 2022

Impact Video: Cerebral Palsy Alliance

This video features Professor Nadia Badawi AM, Professor Alistair McEwan, Paul Rayson and others discussing the incredible impact our partnership will have.

Read More
February 24, 2022

New Partnership with Cerebral Palsy Alliance

We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.

Read More
August 3, 2021

Australian breakthrough to stop heart arteries from clogging

Victor Chang scientist has led landmark research that has the potential to stop arteries of the heart from becoming clogged by targeting a particular gene.

Read More
October 12, 2020

Beneficiary Profile: Victor Chang

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.

Read More
September 23, 2020

Silent wave' of brain damage could follow pandemic

Australia urgently needs to prepare for a "silent wave" of COVID-19, which appears to be taking the form of long-term neurological side effects following infection with the virus.

Read More
September 8, 2020

Beneficiary Profile: Black Dog Institute

1 in 5 of us will experience symptoms of mental illness in any given year. In Australia that’s around 5 million people. And roughly 60% of these people won’t seek help. Learn what Black Dog is doing to create a mentally healthier world for everyone.

Read More
August 10, 2020

Beneficiary Profile: RPA Green Light

Emergency departments are the frontline of health care, with one in seven Australians seeking help from a hospital emergency department every year. Our medical staff depend on research findings to help inform their responses to urgent patient needs.

Read More
July 7, 2020

Beneficiary Profile: The Florey

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.

Read More
June 9, 2020

Beneficiary Profile: Orygen

1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.

Read More
November 22, 2019

Impact Video Series: Sydney Children's Hospital Foundation

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding.

Read More
May 29, 2019

Winning Hearts and Minds

Mark Nelson of Caledonia discusses his connection with the Florey Institute, one of our beneficiaries, and why he's involved with Hearts and Minds.

Read More